CAS: 51746-85-1; 3-(1H-Imidazol-5-yl)Pyridine

该化合物是有机化合物,其特点是其环状结构,包括了一条和一粒环.该化合物通常具有以下特性:在室温下固态,在水和酒精等极地溶剂中具有中度溶解性,因为其环状中存在氮原子,可以进行氢结合.它经常用于医药化学,并且作为协调化学的一种离子,因为它能够与金属离子相协调.两种含氮环的存在都有助于其潜在的生物活动,使其对药物的发展和研究感兴趣.此外,它还可能表现出荧光性,这在各种分析应用中可能有用.

结构式图片

相似化合物

219121-67-2 780749-63-5 945524-57-2

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号93103-29-8 5-PYRIDIN-3-YL-... | CAS号63464-84-6 Oxo-pyridin-3-y... | CAS号254430-69-8 β,β-dimethoxy-3... | CAS号77287-34-4 甲亚胺酸 | CAS号2302-25-2 4-溴-1H-咪唑 | CAS号1692-25-7 吡啶-3-硼酸 | CAS号6221-12-1 3-(2-溴乙酰基)吡啶 | CAS号17694-68-7 3-(2-溴乙酰基)吡啶氢溴酸盐 | CAS号626-55-1 3-溴吡啶 | CAS号100-54-9 3-氰基吡啶 | CAS号173838-67-0 4-[4-(吡啶-3-基)咪唑... | CAS号173838-63-6 4-[4-(吡啶-3-基)咪唑... | CAS号191114-48-4 泰利霉素

合成工艺路线路线简述

    Pyridine-3-Ylglyoxal置于聚合甲醛,氨体系中,用 水,二甲基亚砜 作为反应溶剂,化学反应生成 3-(1H-咪唑-4-基)吡啶
    参考文献:Production Methods Of Imidazole Compound And Salt Thereof And Intermediates Therefor
    标题:Production Methods Of Imidazole Compound And Salt Thereof And Intermediates Therefor
    摘要:一种生产方法,包括将式(6)的卤素化合物或其盐在二甲基亚砜中转化为式(2)的甘醛化合物或其盐的步骤,以及将在前一步骤中获得的式(2)的甘醛化合物或其盐与氨和式(3)的醛化合物或其盐反应的步骤,可以方便地生产式(1)的咪唑化合物或其盐.该咪唑化合物是一种作为药物和农业化学品有用的化合物的合成中间体.该生产方法适用于工业规模生产.其中每个符号如规范中所定义.

    海关参考信息

    专利信息


    专利号:US-9458111-B2
    优先权日:2010-07-29
    标题:Process for the synthesis of substituted urea compounds
    发明人:LEARMONTH DAVID ALEXANDER; BROADBELT BRIAN; WAHNON JORGE BRUNO REIS
    权利人:LEARMONTH DAVID ALEXANDER; BROADBELT BRIAN; WAHNON JORGE BRUNO REIS; BIAL—PORTELA & CA S A
    摘要:A process for preparing a substitute urea of Formula (II) or Formula (I), or a pharmaceutically acceptable salt or ester thereof: n nthe process comprising the reaction of a carbamate of Formula (II′): Formula (I′):n n nwith a primary or secondary amine of the formula R1R2NH, wherein ring A, and R1, R2, R5, V, W, X, Y and Z are as defined herein.

    专利号:US-11078163-B2
    优先权日:2014-01-24
    标 题 :Processes for the synthesis of substituted urea compounds
    发明人:RUSSO DOMENICO; WAHNON JORGE BRUNO REIS; MATON WILLIAM; ESZENYI TIBOR
    权利人:BIAL PORTELA & CA SA; BIAL PORTELA & Cª S A
    摘要:The present invention concerns a process for preparing a compound having the Formula A; or a pharmaceutically acceptable salt or derivative thereof, or for preparing a substituted urea compound of Formula IIa, or a pharmaceutically acceptable salt or ester thereof, the process comprising the reaction of an imidazolyl intermediate of Formula IIa′ with a carbamoyl halide of the formula: R1R2NC(â• O)Hal, wherein Hal represents Cl, F, I or Br, wherein the intermediate of Formula IIa′ is prepared by oxidation of the derivative of R5 and R6, R6-C(â• O)CH2R5 to form a glyoxal intermediate R6-C(â• O)(Câ• O)R5, which is subjected to treatment with ammonium hydroxide and an aldehyde R8CHO to provide the intermediate of Formula IIa′ and wherein the compound substituents are as defined herein.

    专利号:US-2015197503-A1
    优先权日:2012-07-27
    标题 :Process for the synthesis of substituted urea compounds
    发明人:RUSSO DOMENICO; WAHNON JORGE BRUNO REIS; MATON WILLIAM; ESZENYI TIBOR
    权利人:BIAL PORTELA & Cª S A
    摘要:A process for preparing a substituted urea compound of Formula II or Formula I, or a pharmaceutically acceptable salt or ester thereof, Formula II, Formula I the process comprising the reaction of an intermediate of Formula II′ or Formula 1′, Formula II′, Formula I′ with a carbamoyl halide of the formula: R1R2NC(=0)Hal, in a solvent consisting essentially of pyridine, wherein Hal represents Cl, F, I or Br, and wherein ring A, and R1, R2, R5, V, W, X, Y and Z are as defined herein.

    专利号:WO-2004046131-A1
    优先权日:2002-11-20
    标 题:Process for preparation of imidazoles and salts thereof and intermediates thereof
    发明人:SHINTAKU TETSUYA; ITAYA NOBUSHIGE
    权利人:SUMIKA FINE CHEMICALS CO LTD
    摘要:A process which makes it possible to prepare easily imidazoles of the general formula (1) or salts thereof, which serve as intermediates in the synthesis of compounds useful as drugs or agricultural chemicals, and which is suitable for practice even on an industrial scale. The process comprises the step of converting a halide of the general formula (6) or a salt thereof in dimethyl sulfoxide into a glyoxal of the general formula (2) or a salt thereof and the step of reacting the glyoxal or salt thereof obtained in the above step with ammonia and an aldehyde of the general formula (3) or a salt thereof. (A) (In the formulae, each symbol is as defined in the description.)

    专利号:US-2010286211-A1
    优先权日:2004-10-08
    标题:Oxazolidinone derivatives as antimicrobials
    发明人:DAS BISWAJIT; AHMED SHAHADAL; YADAV AJAY SINGH; GHOSH SOMA; GUJRATI ARTI; SHARMA PANKAJ; RATTAN ASHOK
    权利人:DAS BISWAJIT; AHMED SHAHADAL; YADAV AJAY SINGH; GHOSH SOMA; GUJRATI ARTI; SHARMA PANKAJ; RATTAN ASHOK
    摘要:The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria, for example, multiple-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms, for example, Bacterioides spp. and Clostridia spp. species, and acid fast organisms, for example, Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.

    专利号:US-10995078-B2
    优先权日:2013-03-13
    标 题:Compounds and compositions for inhibition of FASN
    发明人:BAIR KENNETH W; LANCIA JR DAVID R; LI HONGBIN; LOCH JAMES; LU WEI; MARTIN MATTHEW W; MILLAN DAVID S; SCHILLER SHAWN E R; TEBBE MARK J
    权利人:FORMA THERAPEUTICS INC
    摘要:The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:
    广州格林泰克化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.greensyn.com
    电话: 020-32290121👤
    📞广州格林泰克化学技术有限公司 ⚠️参考联系方式

    销售电话:020-32290121
    邮箱:conniechen@greensyn.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海齐月化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.cheerchem.com
    电话: 86(21)-50966856 18017651576 13918258956👤
    📞上海齐月化工有限公司 ⚠️参考联系方式

    销售电话:86(21)-50966856 18017651576 13918258956
    邮箱:qiyuehuagong@163.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    上海市金山区朱枫公路9135号枫泾商城4号楼1-335室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    昆山东辰化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.dongchen-chem.com
    电话: 0512-57665358👤
    📞昆山东辰化工有限公司 ⚠️参考联系方式

    销售电话:0512-57665358
    邮箱:sales@dongchen-chem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Quarterly Journal of Pharmacy & Pharmacology., 12(260), 1939
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2004).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知